Cannara Biotech Inc. (LOVE.V)
CAD 1.42
(-1.39%)
CAD 1.42
(-1.39%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 57.26 Million CAD | 59.76% |
| 2022 | 35.84 Million CAD | 110.58% |
| 2021 | 17.02 Million CAD | 567.24% |
| 2020 | 2.55 Million CAD | 21.64% |
| 2019 | 2.09 Million CAD | 384.7% |
| 2018 | 432.63 Thousand CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 19.68 Million CAD | 1.03% |
| 2024 Q1 | 19.48 Million CAD | 6.29% |
| 2024 Q3 | 19.54 Million CAD | -0.7% |
| 2023 Q4 | 18.33 Million CAD | 15.72% |
| 2023 Q1 | 10.31 Million CAD | -12.54% |
| 2023 FY | 57.26 Million CAD | 59.76% |
| 2023 Q2 | 13.03 Million CAD | 26.42% |
| 2023 Q3 | 15.84 Million CAD | 21.51% |
| 2022 FY | 35.84 Million CAD | 110.58% |
| 2022 Q4 | 11.79 Million CAD | 17.16% |
| 2022 Q3 | 10.06 Million CAD | 35.59% |
| 2022 Q2 | 7.42 Million CAD | 13.07% |
| 2022 Q1 | 6.56 Million CAD | 5.28% |
| 2021 Q2 | 2.25 Million CAD | 65.02% |
| 2021 Q1 | 1.36 Million CAD | 133.77% |
| 2021 Q3 | 7.15 Million CAD | 217.1% |
| 2021 Q4 | 6.23 Million CAD | -12.91% |
| 2021 FY | 17.02 Million CAD | 567.24% |
| 2020 FY | 2.55 Million CAD | 21.64% |
| 2020 Q4 | 585.26 Thousand CAD | -23.39% |
| 2020 Q3 | 763.9 Thousand CAD | 14.28% |
| 2020 Q2 | 668.43 Thousand CAD | 25.35% |
| 2020 Q1 | 533.24 Thousand CAD | -3.63% |
| 2019 Q2 | 518.43 Thousand CAD | -0.0% |
| 2019 Q3 | 506.78 Thousand CAD | -2.25% |
| 2019 Q4 | 553.3 Thousand CAD | 9.18% |
| 2019 FY | 2.09 Million CAD | 384.7% |
| 2019 Q1 | 518.44 Thousand CAD | 0.0% |
| 2018 FY | 432.63 Thousand CAD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 254.89 Thousand CAD | -22364.139% |
| CanadaBis Capital Inc. | 22.22 Million CAD | -157.668% |
| Decibel Cannabis Company Inc. | 115.95 Million CAD | 50.62% |
| Delivra Health Brands Inc. | 12.37 Million CAD | -362.596% |
| Entourage Health Corp. | 40.71 Million CAD | -40.644% |
| Lifeist Wellness Inc. | 21.65 Million CAD | -164.361% |
| Medicure Inc. | 21.69 Million CAD | -163.945% |
| PharmaCielo Ltd. | 1.54 Million CAD | -3613.976% |
| Rubicon Organics Inc. | 40.11 Million CAD | -42.735% |
| BioSyent Inc. | 31.59 Million CAD | -81.259% |
| Voyageur Pharmaceuticals Ltd. | - CAD | -Infinity% |